¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"structure activity analysis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® semen analysis ÇÑ±Û Á¤¾× °Ë»ç
¼³¸í   
  ºÎºÎ¿¡°Ô¼­ ÀÓ½ÅÀÌ ¾ÈµÇ´Â °æ¿ì ½Ç½ÃÇϴ ºÒÀÓ °Ë»çÁßÀÇ Çϳª·Î Á¤¾×ÀÇ ¾ç, Á¤ÀÚÀÇ ¿îµ¿¼º, ¸ð¾ç, ¼ö µîÀ» ÃøÁ¤ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
  • alveolar structure
    1. ²Ê¸®±¸Á¶, ÆóÆ÷±¸Á¶ 2. Æ÷»ó±¸Á¶
  • cognitive structure
    ÀÎÁö±¸Á¶
  • structure
    1. ±¸Á¶ 2. Á¶Á÷ 3. ±¸Á¶¹°
  • antibacterial activity
    Ç×±ÕÀÛ¿ë
  • activity
    1. Ȱ¼ºµµ 2. Ȱµ¿, Ȱ¼º 3. -´É
  • biologic activity
    »ý¹°ÇÐÀûȰ¼º
  • caries activity
    ¿ì½ÄȰµ¿
  • electrical activity
    Àü±âȰ¼º
  • enzyme activity
    È¿¼ÒȰ¼º, È¿¼ÒȰ¼ºµµ
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É, ÇǺ기¿ëÇØ´É
  • helper cell activity
    µµ¿ò¼¼Æ÷Ȱ¼º
  • hemolytic activity
    ¿ëÇ÷´É
  • homosexual activity
    µ¿¼º¾ÖÇàÀ§
  • involuntary activity
    ºÒ¼öÀÇȰµ¿
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱ¼ºµµ, Ȱµ¿
  • specific activity
    ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
  • structure
    ±¸Á¶
  • alveolar structure
    ²Ê¸®±¸Á¶, ÆóÆ÷±¸Á¶
  • bone structure
    »À±¸Á¶, °ñ±¸Á¶
  • analysis
    ºÐ¼®
  • antigen analysis
    Ç׿øºÐ¼®
  • path analysis
    °æ·ÎºÐ¼®
  • qualitative analysis
    Á¤¼ººÐ¼®
  • quantitative analysis
    Á¤·®ºÐ¼®
  • statistical analysis
    Åë°èºÐ¼®
  • survival analysis
    »ýÁ¸ºÐ¼®
  • system analysis
    °èÅëºÐ¼®
  • meta-analysis
    ¸ÞŸºÐ¼®
  • self-analysis
    ÀÚ±âºÐ¼®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
  • adnexal structure
    ºÎ¼Ó±¸Á¶
  • alveolar structure
    ²Ê¸®±¸Á¶, ÆóÆ÷±¸Á¶
  • bone structure
    »À±¸Á¶, °ñ±¸Á¶
  • chain structure
    »ç½½±¸Á¶, ¿¬¼â±¸Á¶
  • cognitive structure
    ÀÎÁö±¸Á¶
  • core structure
    Á߽ɱ¸Á¶¹°
  • decidual structure
    Å»¶ô¸·±¸Á¶
  • discoid structure
    ¿ø¹Ý±¸Á¶
  • electron structure
    ÀüÀÚ±¸Á¶
  • immunoglobulin structure
    ¸é¿ª±Û·ÎºÒ¸°±¸Á¶
  • structure
    ±¸Á¶
  • activity
    Ȱ¼ºµµ, Ȱµ¿
  • activity therapist
    Ȱµ¿¿ä¹ý»ç, Ȱµ¿Ä¡·á»ç
  • activity therapy
    Ȱµ¿¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SAR : structure activity relationship
    ±¸Á¶ÀÛ¿ë°ü°è.
  • alveolar structure
    Æ÷»ó±¸Á¶(¡­Ï°ðã).
  • alveolar structure
    ÆóÆ÷±¸Á¶(¡­Ï°ðã)
  • antibody structure
    Ç×ü±¸Á¶(¡­Ï°ðã).
  • antigenic structure
    Ç׿ø±¸Á¶(¡­Ï°ðã).
  • helical structure
    ³ª¼±±¸Á¶(¡­Ï°ðã).
  • hemochorial structure
    Ç÷¾×À¶¸ð¸·±¸Á¶
  • hemodichorial structure
    Ç÷¾×µÎÃþÀ¶¸ð¸·±¸Á¶
  • hemoglobin structure
    Ç÷»ö¼Ò±¸Á¶
  • hemomonochorial structure
    Ç÷¾×ȬÃþÀ¶¸ð¸·±¸Á¶
  • immunoglobulin structure
    ¸é¿ª±Û·ÎºÒ¸° ±¸Á¶
  • personality structure, Jungian theory
    Àΰݱ¸Á¶
  • primary structure
    ÀÏÂ÷±¸Á¶(¡­Ï°ðã).
  • pseudoknot RNA structure
    ¸ÅµìÇü RNA ±¸Á¶
  • quasicrystalline structure
    ÁذáÁ¤±¸Á¶(ñÞÌ¿ïÜϰðã).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • structure activity relationship
    ±¸Á¶-Ȱ¼ºµµ°ü°è.
  • structure activity relationship
    (È­ÇÐ)±¸Á¶ Ȱ¼º »ó°ü°ü°è
  • alveolar structure
    Æ÷»ó±¸Á¶(¡­Ï°ðã).
  • alveolar structure
    ÆóÆ÷±¸Á¶(¡­Ï°ðã)
  • antibody structure
    Ç×ü±¸Á¶(¡­Ï°ðã).
  • antigenic structure
    Ç׿ø±¸Á¶(¡­Ï°ðã).
  • atomic structure
    ¿øÀÚ±¸Á¶(¡­Ï°ðã).
  • atomic structure
    ¿øÀÚ±¸Á¶
  • bone structure
    »À±¸Á¶, °ñ±¸Á¶(Íéϰðã).
  • chain structure
    ¿¬¼â±¸Á¶(ææáðϰðã).
  • chemical structure
    È­ÇÐÀû ±¸Á¶
  • chemical structure
    È­Çб¸Á¶(¡­Ï°ðã).
  • cognitive structure
    ÀÎÁö±¸Á¶(ìãò±Ï°ðã)
  • core structure
    Á᫐ ±¸Á¶¹°
  • decidua structure
    Å»¶ô¸·±¸Á¶
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Intra-articular structure
    °üÀý¼Ó±¸Á¶¹°
    [¿¾ ¿ë¾î] °üÀý³»±¸Á¶
  • Typical structure
    ÀüÇüÀû±¸Á¶
    [¿¾ ¿ë¾î] ÀüÇüÀû±¸Á¶
  • Decidua structure
    Å»¶ô¸·±¸Á¶
    [¿¾ ¿ë¾î] Å»¶ô¸·±¸Á¶
  • Hemodichorial structure
    Ç÷¾×µÎÃþÀ¶¸ð¸·±¸Á¶
    [¿¾ ¿ë¾î] Ç÷ÀÌÀ¶¸ð¸·¼º±¸Á¶
  • Hemochorial structure
    Ç÷¾×À¶¸ð¸·±¸Á¶
    [¿¾ ¿ë¾î] Ç÷À¶¸ð¸·¼º±¸Á¶
  • Hemomonochorial structure
    Ç÷¾×ȬÃþÀ¶¸ð¸·±¸Á¶
    [¿¾ ¿ë¾î] Ç÷´ÜÀ¶¸ð¸·¼º±¸Á¶
  • Discoid structure
    ¿ø¹Ý±¸Á¶
    [¿¾ ¿ë¾î] ¿ø¹Ý»ó±¸Á¶
  • Villous structure
    À¶¸ð±¸Á¶
    [¿¾ ¿ë¾î] À¶¸ð±¸Á¶
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • covalent structure analysis
    °øÀ¯°áÇÕ ±¸Á¶ºÐ¼®(ÍìêóÌ¿ùêϰðãÝÂà°)
  • activity
    Ȱ·®(üÀÕá)
  • activity
    Ȱ¼º (üÀàõ)
  • activity coefficient
    Ȱ·®°è¼ö (üÀÕá°èâ¦)
  • catalytic center activity
    Ã˸ÅÁß½É È°¼º(õºØÚñéãýüÀàõ)
  • concentration of enzymatic activity
    È¿¼ÒȰ¼º ³óµµ(ý£áÈüÀàõÒØÓø)
  • enzymatic activity
    È¿¼Ò Ȱ¼º (ý£áÈüÀàõ)
  • intrinsic activity
    ³»ÀçȰ¼º(Ò®î¤üÀàõ)
  • mean activity coefficient
    Æò±ÕȰµ¿°è¼ö(øÁгüÀÔÑͪâ¦)
  • mean ionic activity coefficient
    Æò±Õ(øÁг) ÀÌ¿ÂȰ¼º°è¼ö(üÀàõͪâ¦)
  • molar activity
    ¸ô Ȱ¼º(üÀàõ)
  • molecular activity
    ºÐÀÚȰ¼º(ÝÂí­üÀàõ)
  • myotropic activity
    ±Ù°­È­È°¼º(ÐÉË­ûùüÀàõ)
  • optical activity
    ±¤ÇРȰ¼º(ÎÃùÊüÀàõ)
  • Raman optical activity
    ¶ó¸¸ ±¤ÇРȰ¼º(µµ)(ÎÃùÊüÀàõ(Óø))
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱ¼ºµµ, Ȱµ¿µµ
  • core structure
    Á᫐ ±¸Á¶¹°
  • helical structure
    ³ª¼±±¸Á¶
  • structure
    ±¸Á¶
  • analysis
    ºÐ¼®
  • case analysis
    Áõ·ÊºÐ¼®
  • computerized image analysis
    ÄÄÇ»ÅÍ¿µ»óºÐ¼®
  • image analysis
    ¿µ»óºÐ¼®
  • in vitro analysis
    °ü³»ºÐ¼®
  • in vivo analysis
    »ýü³»ºÐ¼®
  • infrared spectroscopic analysis
    Àû¿Ü¼±ºÐ±¤ºÐ¼®
  • quantitative analysis
    Á¤·®ºÐ¼®
  • radiometric analysis
    ¹æ»ç¼±ºÐ¼®
  • sequential analysis
    ¼øÂ÷ÀûºÐ¼®
  • spectral analysis
    ½ºÆåÆ®·³ºÐ¼®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SA salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame...
NYHA New York Heart Association
  Heart Disease¿¡ ´ëÇÑ Functional Classification
 &nbs...
MRA magnetic resonance angiography; main renal artery; marrow repopulation activity; medical record anal...
QSAR quantitative structure-activity relationship
SAR scatter/air ratio; seasonal allergic rhinitis; sexual attitude reassessment; slowly adapting recepto...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
QSAR Quantitative Structure Activity Relationship
SAR Structure activity relationship
3-D-QSAR Three-dimensional quantitative structure-activity relationship
HAA Hospital Activity Analysis
CASE Computer Automated Structure Evaluation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ancillary structure
    º¸Á¶ Á¶Á÷
  • atomic structure
    ¿øÀÚ ±¸Á¶
  • bone structure
    °ñ°Ý, »À ±¸Á¶, °ñ ±¸Á¶
    µ¿¹°ÀÇ ¸öÀ» ÁöÅÊÇϰí üÇüÀ» Çü¼ºÇÏ´Â ±â°ü. ü°Ý ¶Ç´Â ÀÚ¼¼¸¦ ÁöÅÊÇϸç, ¿îµ¿ÀÇ Åä´ë°¡ µÇ°í, ³»ÀåÀÇ ¸ðµç ±â°üÀ» º¸È£ÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. ôÃßµ¿¹°¿¡¼­´Â ±âº»ÀûÀ¸·Î °ñ°Ý¿¡ °øÅëÁ¡ÀÌ Àִµ¥, µÎ°ñ°ú ôÃß°¡ Áß½ÉÀ» ÀÌ·ç¸ç, °Å±â¿¡ »çÁö°ñÀÌ À̾îÁø´Ù. µ¿¹°ÀÇ Á¾·ù¿¡ µû¶ó¼­ °ñ°ÝÀÇ Çü»óÀ̳ª ¼ö·® µî¿¡´Â Â÷À̰¡ ÀÖ´Ù. °ñ°ÝÀÇ °áÇÕ ¹æ¹ý¿¡´Â ´ÙÀ½ÀÇ 3Á¾·ù°¡ ÀÖ´Ù. ¨ç °üÀý °áÇÕ : °ñ°ÝÀÇ ´ëºÎºÐÀº °üÀý·Î¼­ ¿òÁ÷À̵µ·Ï µÇ¾î ÀÖ´Ù. ¨è ºÀÇÕ : µÎ°³°ñÀº °ñ°ÝÀÇ °áÇպκÐÀÌ Åé´Ïó·³ µÇ¾î ÀÖ¾î Åé´Ï¹ÙÄû¸¦ ¸ÂÃá µíÀÌ °áÇյǾî ÀÖ´Ù. ¨é ¿¬°ñ °áÇÕ : Á¿ìÀÇ Ä¡°ñÀ̳ª ôÃß°ñ »çÀÌ¿¡´Â ¿¬°ñ Á¶Á÷ÀÌ ÀÖ¾î ±×°ÍÀÌ °ñ°Ý°ú °ñ°ÝÀ» °áÇÕ½ÃŲ´Ù.
  • capsule structure
    ³¶ ±¸Á¶, °üÀý³¶ ±¸Á¶
  • chain structure
    ¿¬¼â ±¸Á¶
  • chemical structure
    È­ÇÐ ±¸Á¶
  • cubic structure
    µî¹æ ±¸Á¶, ÀÔ¹æ ±¸Á¶
  • decidua structure
    Å»¶ô¸· ±¸Á¶
  • diencephalic structure
    °£³ú ±¸Á¶
  • domain structure
    ¿µ¿ª ±¸Á¶
  • electron structure of atom
    ¿øÀÚÀÇ ÀüÀÚ ±¸Á¶
  • encapsulated structure
    Çdz¶ ±¸Á¶
  • extracranial structure
    µÎ°³¿Ü ±¸Á¶¹°
  • locomotor structure
    ¿îµ¿ ±¸Á¶¹°
  • monoclinic structure
    ´Ü»ç ±¸Á¶
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
structure activity analysis Study in which systematic variation in the structure of a compound is correlated with its activity, in an attempt to determine the characteristics of the (receptor) site at which it acts.
(18 Nov 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
structure-activity relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Other factors contributing to structure-activity relationship include chemical reactivity, electronic effects, resonance, and inductive effects.
(12 Dec 1998)
activity 1. The state of being active, the ability to produce some effect, the extent of some function or action.
2. <chemistry> A thermodynamic quantity that represents the effective concentration of a solute in a nonideal solution, if concentrations are replaced by activities, the equations for equilibrium constants, electrode potentials, osmotic pressure, boiling point elevation, freezing point depression and vapour pressures of volatile solutes are converted from approximations that hold only for dilute solutions to exact equations that hold for all concentrations. The activity is equal to the product of the concentration and the activity coefficient, a dimensionless number measuring deviation from nonideality. Symbol a.
The potential or true thermodynamic activity of a substance, as opposed to its molar concentration.
3. <radiobiology> The number of nuclear transitions or disintegrations occurring in a given quantity of radioactive material per unit time. The SI unit of activity is s-1. The special name for the unit of activity is becquerel (Bq). The previously used special unit of activity, curie (Ci), is being replaced by the becquerel. 1 Bq = 2.7 x E-11 Ci. 1 Ci = 3.7 x E10 Bq.
4. Optical activity.
(16 Dec 1997)
activity coefficient <chemistry> The factor by which the value of a concentration of a solute must be multiplied to determine its true thermodynamic activity.
(06 May 1997)
activity cycles Bouts of physical irritability or movement alternating with periods of quiescence. It includes biochemical activity and hormonal activity which may be cellular. These cycles are shorter than 24 hours and include sleep-wakefulness cycles and the periodic activation of the digestive system.
(12 Dec 1998)
activity, drug A measure of the physiological response a drug produces in the body. A less active drug produces less response (and visa versa).
(12 Dec 1998)
blocking activity The repression or elimination of electrical activity in the brain by the arrival of a sensory stimulus.
(05 Mar 2000)
blood bactericidal activity Native bactericidal property of blood due to normally occurring antibacterial substances such as beta lysin, leukin, etc.
(12 Dec 1998)
melanoma growth stimulatory activity Cytokine of the C X C subfamily. Potent mitogen. Activates and is chemotactic for, neutrophils.
(18 Nov 1997)
water activity <chemistry> An expression of the relative availability of water in a substance. Pure water has an water activity of 1.000. The water activity of a solution is one-hundredth its relative humidity.
(09 Oct 1997)
motor activity The physical activity of an organism as a behavioural phenomenon.
(12 Dec 1998)
complement haemolytic activity assay Usual screening assay for complement. Dilutions of the serum to be tested are added to antibody-coated erythrocytes and the percentage of lysis is measured. The values are expressed by ch50, haemolytic complement units per milliliter, which is the dilution of serum required to lyse 50 percent of the erythrocytes in the assay.
(12 Dec 1998)
plasma renin activity The estimation of renin in plasma by measuring the rate of formation of angiotensin I or II.
(05 Mar 2000)
solar activity Any type of variation in the appearance of energy output of the sun.
(12 Dec 1998)
specific activity 1. <chemistry> The number of activity units (whatever is appropriate) per unit of mass, volume or molarity.
2. <radiobiology> Total activity of a given nuclide per gram of a compound, element or radioactive nuclide. Perhaps most often usage, in the context of radiochemicals, the number of microcuries per micromole.
(16 Dec 1997)
nonsuppressible insulin-like activity A blood protein (nsila) which mimics the biological activity of insulin in serum, but is not suppressed by insulin antibodies. During acid-ethanol extraction of cohn fraction III, 10% of the activity is found in the supernatant (nsila-s) and the remaining activity in the precipitate (nsila-p). The latter is a large molecular compound, much less stable than the soluble fraction. Nsila-s is a more potent growth factor than insulin and exhibits sulfation activity.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱµ¿,Ȱ±â
  • activity
    Ȱµ¿;Ȱ¾à;Ȱ±â;ȰȲ;´Éµ¿¼º;Ȱµ¿¹üÀ§
  • crew activity planning
    (¿ìÁÖ¼± ºñÇàÁßÀÇ) ½Â¹«¿ø ÀÛ¾÷°èȹ
  • extracurricular activity
    °ú¿Ü Ȱµ¿;(¼Ó)ºÎÁ¤(ºÎµµ´ö)ÇàÀ§;¿Üµµ
  • extravehicular activity
    (¿ìÁÖÀÎÀÇ)¼±¿Ü Ȱµ¿
  • structure
    ±¸Á¶,Á¶Á÷,°ÇÃà(¹°)
  • constituent structure
    ±¸¼º¿ä¼Ò ±¸Á¶
  • cryptoexplosion structure
    ÀǺÐÈ­ ±¸Á¶
  • deep structure
    ½ÉÃþ ±¸Á¶((º¯Çü)»ý¼º ¹®¹ý¿¡¼­ ¹®ÀåÀÇ Àǹ̸¦ °áÁ¤ÇÏ´Â ½É¸®Àû ½ÇÀç·Î¼­ÀÇ ±âÀú ±¸Á¶)
  • fine structure
    ¹Ì¼¼±¸Á¶
  • molecular structure
    ºÐÀÚ ±¸Á¶
  • phrase structure grammar
    ±¸±¸Á¶ ¹®¹ý
  • power structure
    ±Ç·Â ±â±¸
  • primary structure
    ÃÊ¿øÀû ±¸Á¶¹°(ÃÖ¼ÒÇÑÀÇ Á¶Çü ¼ö´ÜÀ¸·Î Á¦À۵Ǵ ÀüÀ§ Á¶°¢)
  • structure
    ¹°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á